Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Table 1
- docx file
Supplementary Table 2
- docx file
Supplementary Table 3
- docx file